Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation

Nonalcoholic fatty liver disease (NAFLD), which includes simple steatosis, steatohepatitis, fibrosis, and cirrhosis, is characterised by abnormal fat accumulation in the liver in the absence of excessive alcohol intake. In patients with type 2 diabetes (T2D), concurrent NAFLD might increase the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jia-Hung, Chao, Jung, Chang, Ming-Ling, Peng, Wen-Huang, Cheng, Hao-Yuan, Liao, Jiunn-Wang, Pao, Li-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017161/
https://www.ncbi.nlm.nih.gov/pubmed/27612024
http://dx.doi.org/10.1038/srep33102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017161/
https://www.ncbi.nlm.nih.gov/pubmed/27612024
http://dx.doi.org/10.1038/srep33102

Ejemplares similares